Alto Neuroscience develops drug candidates for psychiatric disorders, using biomarkers found through data analytics to select patients. It last closed at $25.37 on Nov 20, down 4.30% on the day. The next earnings report for ANRO is expected around Mon, Mar 15, 2027. For the quarter ended Sep 2026, ANRO reported EPS of -$0.54. Over its last 8 reports the stock moved an average of 7.3% the session after earnings. Over the last 12 months ANRO insiders bought $0 of stock on the open market and sold $5.6M, according to SEC Form 4 filings.
AI Auto Pilots
Is ANRO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold ANRO.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on ANROStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
ANRO · as of the Nov 20 close · updated each morning
Uptrend
The stock is 0% below its 20 day and 1% below its 50 day average. It is 1% above its 200 day average, so the longer trend is still up. Momentum is improving (RSI 49). The nearest support is the 200 day average at $25.00, and the nearest resistance the Pivot at $25.42.
Short trendBullish
Long trendBullish
MomentumImproving
StretchNormal
VolatilityHigh, 8.2%/day
Key levels
$37.4852 week high+47.7%
$28.30Swing high (Jun 30)+11.5%
$28.02100 day average+10.4%
$26.43Pivot R1+4.2%
$25.5850 day average+0.8%
$25.42Pivot+0.2%
$25.3720 day average+0.0%
$25.37Last close
$25.00200 day average−1.5%
$24.35Pivot S1−4.0%
$24.30Swing low (Jul 7)−4.2%
$12.5152 week low−50.7%
Indicators
RSI (14)
48.54
Middle of its range
Neutral
MACD
0.50
Above its signal line
Bullish
Stochastic
36.3
Middle of its range
Neutral
ADX (14)
24.3
Weak trend
Williams %R
-69.7
Oversold below −80, overbought above −20
Neutral
CCI (20)
1.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+0.8%
Change over 10 sessions
Bullish
ATR (14)
$2.08
Typical daily range, 8.2% of price
MA 10Below
MA 20Above
MA 50Below
MA 100Below
MA 200Above
Moving sideways
Short trendNeutral
Long trendNot enough history
MomentumFading
StretchNormal
VolatilityNormal, 16.1%/day
Key levels
$37.4852 week high+47.7%
$28.30Swing high (Jun 30)+11.5%
$28.02100 day average+10.4%
$26.43Pivot R1+4.2%
$25.5850 day average+0.8%
$25.42Pivot+0.2%
$25.3720 day average+0.0%
$25.37Last close
$25.00200 day average−1.5%
$24.35Pivot S1−4.0%
$24.30Swing low (Jul 7)−4.2%
$12.5152 week low−50.7%
Indicators
RSI (14)
49.58
Middle of its range
Neutral
MACD
0.48
Below its signal line
Bearish
Stochastic
33.2
Middle of its range
Neutral
ADX (14)
31.7
Trending up
Williams %R
-74.9
Oversold below −80, overbought above −20
Neutral
CCI (20)
-34.2
Oversold below −100, overbought above 100
Neutral
Rate of change
−20.7%
Change over 10 sessions
Bearish
ATR (14)
$4.09
Typical daily range, 16.1% of price
MA 10Above
MA 20Below
MA 50Above
MA 100Above
MA 200–
What happened before, for ANRO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ANRO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for ANROHow many large options trades hit ANRO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in ANRO in the last 90 days.
From SEC Form 4 filings by ANRO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ANRO is in one of them and how their past ANRO trades turned out.
Alto Neuroscience is a pharmaceutical company based in Mountain View, California, that develops drugs for psychiatric disorders. It uses data analytics and machine learning to find biomarkers that can help identify which patients are most likely to benefit from a given treatment. The company is developing its product candidates for conditions including major depressive disorder and schizophrenia, and it has not yet commercialized a drug. Its work is aimed at patients with these conditions and the clinicians who treat them.